Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis [2]

Journal of Applied Physiology

Volumn 102, Issue 2, 2007, Pages 820-

  Shoelson, Steven E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INSULIN; INSULIN SENSITIZING AGENT; INTERLEUKIN 6; GLUCOSE;

CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXERCISE; FATTY LIVER; IMMUNE RESPONSE; IMMUNOMODULATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; HOMEOSTASIS; HUMAN; INFLAMMATION; METABOLISM; MOUSE; NOTE; PHYSIOLOGY;

ANIMALS; EXERCISE; GLUCOSE; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MICE;

EID: 33846885005     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01353.2006     Document Type: Letter

References (4)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol 6: 508-519, 2006.
2. Mooney RA. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. In press.
3. Pedersen BK, Febbraio MA. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. In press.
4. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 116: 1793-1801, 2006.